<DOC>
	<DOCNO>NCT00280735</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , carboplatin docetaxel , work different way stop growth tumor cell , either kill cell stop divide . Giving carboplatin together docetaxel surgery may kill tumor cell remain surgery . PURPOSE : This phase II trial study well give carboplatin together docetaxel work treat patient stage I , stage II , stage III non-small cell lung cancer .</brief_summary>
	<brief_title>Ph II Adjuvant Carboplatin/Docetaxel Curatively Resected Stage I-IIIA NSCLC</brief_title>
	<detailed_description>OBJECTIVES : Primary - Evaluate feasibility adjuvant carboplatin docetaxel patient resect stage I , II , IIIA non-small cell lung cancer . Secondary - Determine toxicity regimen patient . - Determine survival pattern patient treated regimen . - Assess pattern recurrence patient treat regimen . OUTLINE : Patients receive carboplatin IV day 1 docetaxel IV day 1 . Treatment repeat every 3 week 4 course absence disease progression unacceptable toxicity . After completion study treatment , patient follow every 3 month 2 year every 6 month 3 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Inclusion criterion : Histologically confirm nonsmall cell lung cancer Stage IIIIA disease Must undergone complete resection Must begin adjuvant chemotherapy within 8 week surgical resection PATIENT CHARACTERISTICS : Eastern Cooperative Oncology Group ( ECOG ) performance status 01 Absolute neutrophil count ≥ 1,500/mm^3 Hemoglobin ≥ 8.0 g/dL Platelet count ≥ 100,000/mm^3 Serum creatinine normal OR creatinine clearance ≥ 40 mL/min Bilirubin normal Alkaline phosphatase ( AP ) , Aspartate aminotransferase ( AST ) , Alanine transaminase ( ALT ) must meet 1 follow criterion : AP normal AND AST ALT ≤ 5 time upper limit normal ( ULN ) AP ≤ 2.5 time ULN AND AST ALT ≤ 1.5 time ULN AP ≤ 5 time ULN AND AST ALT normal Negative pregnancy test Fertile patient must use effective contraception least 3 month study therapy No breastfeed No peripheral neuropathy ≥ grade 2 No history severe hypersensitivity docetaxel polysorbate 80 Prior history malignancy allow provided attend medical oncologist believe adjuvant chemotherapy indicate potentially benefit patient PRIOR CONCURRENT THERAPY : 28 week since prior surgery recover</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage III non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
</DOC>